|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.12 EUR | -1.08% |
|
-2.36% | +5.96% |
| 05:29am | Moody's Affirms Eurofins Scientific's Ratings, Outlook on Solid Operating Performance in FY25 | MT |
| Feb. 17 | CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €71.71 | +7.28% | 14 | ||||||
| CHF 676.22 | +28.66% | 23 | ||||||
| ₩253,695.65 | +28.52% | 23 | ||||||
| $409.68 | +37.01% | 25 | ||||||
| $235.52 | +32.41% | 21 | ||||||
| $129.35 | +27.83% | 20 | ||||||
| $246.05 | +18.54% | 16 | ||||||
| $489.62 | +5.1% | 13 | ||||||
| $93.9 | +18.19% | 22 | ||||||
| $55.23 | +17.81% | 15 | ||||||
| $77.5 | +51.1% | 14 | ||||||
| $75.25 | +30.08% | 12 | ||||||
| $600.71 | +84.77% | 17 | ||||||
| $197.2 | +9.81% | 15 | ||||||
| €108.72 | +9.27% | 6 | ||||||
| $148.57 | +34.82% | 14 | ||||||
| $119.71 | +39.02% | 21 | ||||||
| CN¥67.77 | +20.89% | 14 | ||||||
| $111.07 | -2.82% | 14 | ||||||
| Average | 13,558.39 | +26.23% | 17 | ||||||
| Weighted average by Cap. | 25,391.11 | +27.38% | 19 |
- Stock Market
- Equities
- ERF Stock
- Sector Eurofins Scientific SE
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
